MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer

Y Z Kuo1, Y H Tai, H I Lo

  • 1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Oral Diseases
|June 5, 2013
PubMed
Abstract

Insights

MicroRNA-99a (miR-99a) down-regulation promotes oral cancer progression by increasing Myotubularin-related protein 3 (MTMR3). Targeting MTMR3 offers a potential therapeutic strategy for oral cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oral cancer is a significant global health concern.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • Dysregulation of specific miRNAs, like miR-99a, is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of deregulated miR-99a in oral cancer.
  • To identify downstream targets of miR-99a.
  • To explore the clinical potential of miR-99a and its targets in oral cancer treatment.

Main Methods:

  • Confirmation of miR-99a deregulation in oral cancer cell lines and clinical specimens.
  • Functional assays including cell proliferation, migration, invasion, and metastasis.
  • Identification of miR-99a targets using luciferase reporter assays and genetic manipulation.
  • Analysis of inverse miR-99a and target expression in clinical samples via real-time PCR and Western blot.

Main Results:

  • miR-99a was consistently down-regulated in oral cancer.
  • Restoring miR-99a expression inhibited oral cancer cell migration and invasion.
  • Myotubularin-related protein 3 (MTMR3) was identified as a novel, evolutionarily conserved target of miR-99a.
  • Silencing MTMR3 reduced oral cancer cell proliferation, migration, and invasion.
  • An inverse correlation between miR-99a and MTMR3 protein expression was observed in oral cancer.

Conclusions:

  • miR-99a suppresses oral cancer cell migration and invasion, partly by down-regulating MTMR3.
  • MTMR3 represents a potential therapeutic target for oral cancer intervention.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...